Rare Disease Issues. H.R.4299: Protecting Patient Access to Cancer and Complex Therapies Act.
Literal federal measure citations: H.R.4299
2026 · 3rd Quarter (July 1 - Sep 30)
TAKEDA PHARMACEUTICALS AMERICA, INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Filing UUID
- e38c73e0-78d4-4791-8313-39550f377fff
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General Medicare/Medicaid Issues. Implementation of Inflation Reduction Act of 2022.
Issues related to tariff and trade policy.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.